No headlines found.
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
Globe Newswire (Thu, 23-Jul 8:00 AM ET)
Globe Newswire (Tue, 7-Jul 8:00 PM ET)
Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1
Globe Newswire (Tue, 19-May 8:00 AM ET)
Bone Biologics - Warrants trades on the stock market under the symbol BBLGW.
As of July 31, 2026, BBLGW stock price was flat at $9.85 with 2 million shares trading.
BBLGW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, BBLGW traded as high as $200.64 and as low as $.70.
BBLGW has underperformed the market in the last year with a price return of -29.6% while the SPY ETF gained +18.9%. BBLGW has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -17.9% and -29.6%, respectively, while the SPY returned +4.2% and -0.5%, respectively.
BBLGW support price is $8.21 and resistance is $11.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BBLGW shares will trade within this expected range on the day.
